Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis.

Publication Type Letter
Authors Krueger J, Murrell D, Garcet S, Navrazhina K, Lee P, Muscianisi E, Blauvelt A
Journal J Allergy Clin Immunol
Volume 147
Issue 3
Pagination 1107-1109.e2
Date Published 09/28/2020
ISSN 1097-6825
Keywords Angiotensin-Converting Enzyme 2, Anti-Inflammatory Agents, Antibodies, Monoclonal, Humanized, Psoriasis, Skin
DOI 10.1016/j.jaci.2020.09.021
PubMed ID 33002515
PubMed Central ID PMC7834246
Back to Top